Every year, millions of people suffer an ischemic stroke, which occurs when a blood clot blocks blood flow to part of the brain.
The longer the blockage remains, the more brain cells die. Fast treatment is essential because brain tissue cannot survive long without oxygen.
One of the biggest advances in stroke medicine is mechanical thrombectomy. During this procedure, doctors use special devices to remove the clot and restore blood flow.
Many patients who once faced severe disability can now recover much better because of this treatment. Yet doctors have faced a frustrating problem. Even when scans show the artery has been reopened, many patients still do not regain their independence.
Scientists think this happens because restoring blood flow in the main artery is only part of the story. Tiny blood vessels inside the brain may remain damaged, and the brain’s normal ability to regulate blood flow may not work properly after a stroke.
Blood pressure therefore becomes extremely important. If it is too high, bleeding may occur. If it is too low, injured brain tissue may not receive enough oxygen.
Researchers at the Sant Pau Research Institute wanted to find out whether blood pressure goals should be personalized instead of using the same target for everyone. Their HOPE clinical trial included 440 patients from 11 hospitals across Spain.
Participants were randomly assigned to either standard treatment or a new strategy that matched blood pressure goals to the amount of blood flow restored after thrombectomy.
People whose blood vessels had been almost completely reopened were treated with lower blood pressure targets to protect the brain from damage caused by restored blood flow.
Those whose blood flow remained partly blocked were allowed to have slightly higher blood pressure to help maintain circulation to vulnerable brain tissue. Patients were monitored carefully for three days while doctors adjusted treatment as needed.
Three months later, the difference between the groups was clear. Sixty percent of patients receiving personalized care achieved functional independence, compared with 47.1 percent in the standard-care group. The individualized approach also resulted in fewer cases of bleeding in the brain and did not increase deaths or serious side effects.
The investigators presented the findings at the annual European Stroke Organisation Conference, and the research was published in JAMA Neurology. According to the research team, these results suggest that understanding each patient’s brain circulation after thrombectomy may be more important than following one fixed blood pressure target.
The study also sends a broader message. Modern stroke treatment is not finished when doctors remove the clot. Careful monitoring during the hours after the procedure may strongly influence whether brain tissue survives and whether patients recover the ability to walk, speak, and care for themselves.
Although the findings are promising, the researchers caution that more work remains. The trial enrolled fewer patients than originally planned, so additional international studies are needed to verify the benefits before this approach becomes standard practice.
Study review and analysis: The HOPE trial provides high-quality evidence because it used random assignment, reducing bias between treatment groups. The improvement in recovery was clinically important, and the absence of extra safety problems makes the findings especially encouraging.
However, early trial closure means the evidence should be confirmed in larger studies. If confirmed, the research could represent a major step toward personalized stroke treatment rather than a one-size-fits-all approach.
If you care about blood pressure, please read studies about unhealthy habits that could increase high blood pressure risk, and eating eggs in a healthy diet may reduce risks of diabetes, high blood pressure.
For more information about blood pressure, please see recent studies that early time-restricted eating could help improve blood pressure, and results showing 12 foods that lower blood pressure.
Source: Sant Pau Research Institute (IR Sant Pau).
